AKTS
Income statement / Annual
Last year (2025), Aktis Oncology Inc's total revenue was $6.50 M,
an increase of 336.92% from the previous year.
In 2025, Aktis Oncology Inc's net income was -$63.73 M.
See Aktis Oncology Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$6.50 M |
$1.49 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$6.50 M
|
$1.49 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
1
|
0
|
0
|
| Research and Development Expenses |
$67.45 M
|
$40.95 M
|
$25.92 M
|
$14.30 M
|
| General & Administrative Expenses |
$12.60 M
|
$11.31 M
|
$7.68 M
|
$5.11 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.60 M
|
$11.31 M
|
$7.68 M
|
$5.11 M
|
| Other Expenses |
$1.13 M
|
$1.28 M
|
$1.20 M
|
$356.00 K
|
| Operating Expenses |
$81.18 M
|
$53.54 M
|
$34.79 M
|
$19.76 M
|
| Cost And Expenses |
$81.18 M
|
$53.54 M
|
$34.79 M
|
$19.76 M
|
| Interest Income |
$11.01 M
|
$8.10 M
|
$5.38 M
|
$1.65 M
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.33 M
|
$1.58 M
|
$1.20 M
|
$445.00 K
|
| EBITDA |
-$72.36 M |
-$50.48 M |
-$33.60 M |
-$19.32 M |
| EBITDA Ratio |
-11.14
|
-33.94
|
0
|
0
|
| Operating Income Ratio |
-11.5
|
-35
|
0
|
0
|
| Total Other Income/Expenses Net |
$10.95 M
|
$8.07 M
|
$6.15 M
|
$1.84 M
|
| Income Before Tax |
-$63.73 M
|
-$43.98 M
|
-$28.64 M
|
-$17.93 M
|
| Income Before Tax Ratio |
-9.81
|
-29.58
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$63.73 M
|
-$43.98 M
|
-$28.64 M
|
-$17.93 M
|
| Net Income Ratio |
-9.81
|
-29.58
|
0
|
0
|
| EPS |
-1.19 |
-1.26 |
-0.82 |
-0.51 |
| EPS Diluted |
-1.19 |
-1.26 |
-0.82 |
-0.51 |
| Weighted Average Shares Out |
$52.52 M
|
$34.86 M
|
$34.86 M
|
$34.86 M
|
| Weighted Average Shares Out Diluted |
$52.52 M
|
$34.86 M
|
$34.86 M
|
$34.86 M
|
| Link |
|
|
|
|
